Format

Send to

Choose Destination
Nat Biotechnol. 2016 Aug;34(8):869-74. doi: 10.1038/nbt.3620. Epub 2016 Jun 27.

Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells.

Kleinstiver BP1,2,3,4, Tsai SQ1,2,3,4, Prew MS1,2,3, Nguyen NT1,2,3, Welch MM1,2,3, Lopez JM1,2,3,4, McCaw ZR1,2,5, Aryee MJ1,2,4,5, Joung JK1,2,3,4.

Author information

1
Molecular Pathology Unit, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
2
Center for Cancer Research, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
3
Center for Computational and Integrative Biology, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
4
Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA.
5
Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.

Abstract

The activities and genome-wide specificities of CRISPR-Cas Cpf1 nucleases are not well defined. We show that two Cpf1 nucleases from Acidaminococcus sp. BV3L6 and Lachnospiraceae bacterium ND2006 (AsCpf1 and LbCpf1, respectively) have on-target efficiencies in human cells comparable with those of the widely used Streptococcus pyogenes Cas9 (SpCas9). We also report that four to six bases at the 3' end of the short CRISPR RNA (crRNA) used to program Cpf1 nucleases are insensitive to single base mismatches, but that many of the other bases in this region of the crRNA are highly sensitive to single or double substitutions. Using GUIDE-seq and targeted deep sequencing analyses performed with both Cpf1 nucleases, we were unable to detect off-target cleavage for more than half of 20 different crRNAs. Our results suggest that AsCpf1 and LbCpf1 are highly specific in human cells.

PMID:
27347757
PMCID:
PMC4980201
DOI:
10.1038/nbt.3620
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center